Dromer F, Perronne C, Barge J, Vilde J L, Yeni P
Laboratoire des Infections Expérimentales, Faculté Xavier Bichat, Paris, France.
Clin Exp Immunol. 1989 Dec;78(3):412-7.
Although cellular immunity has a crucial role during cryptococcosis, several in vitro studies have pointed out the importance of IgG anti-Cryptococcus neoformans antibodies and complement components during phagocytosis of the yeast by polymorphonuclear leucocytes and monocytes. We investigated the role of complement and specific antibodies in host defences against experimental cryptococcosis, using a monoclonal IgG1 antibody (E1) specific for cryptococcal capsular polysaccharide, and mice congenitally sufficient or deficient in the fifth component of complement (C5). During in vitro experiments, E1 and the normal mouse serum from C5-sufficient and -deficient mice were unable to inhibit the growth of C.neoformans. However, E1 was an efficient opsonin for the ingestion of C. neoformans by mouse peritoneal macrophages, acting in synergy with normal mouse serum. In vivo, E1 was protective in heavily infected C5-deficient mice (DBA/2) dying from an early acute pneumonia, but not in C5-sufficient mice (BALB/c) and in DBA/2 mice infected with a smaller inoculum dying from a late progressive meningo-encephalitis. Although protection against pneumonia is attributed to a local recruitment of phagocytes in C5-sufficient mice, this was not observed in C5-deficient mice protected with E1. In this case, IgG anti-C. neoformans antibodies seem to be an alternative for an efficient opsonization of the yeasts. Altogether, these data suggest that two main mechanisms may protect infected mice from an early fatal pneumonia: the efficient opsonization of the yeast by complement and the recruitment of phagocytes in infected tissues.
尽管细胞免疫在隐球菌病过程中起着关键作用,但多项体外研究指出,IgG抗新型隐球菌抗体和补体成分在多形核白细胞和单核细胞吞噬酵母的过程中具有重要意义。我们使用针对隐球菌荚膜多糖的单克隆IgG1抗体(E1),以及先天性补体第五成分(C5)充足或缺乏的小鼠,研究了补体和特异性抗体在宿主抗实验性隐球菌病防御中的作用。在体外实验中,E1以及来自C5充足和缺乏小鼠的正常小鼠血清均无法抑制新型隐球菌的生长。然而,E1是小鼠腹膜巨噬细胞摄取新型隐球菌的有效调理素,与正常小鼠血清协同发挥作用。在体内,E1对因早期急性肺炎而濒死的重度感染C5缺乏小鼠(DBA/2)具有保护作用,但对C5充足小鼠(BALB/c)以及感染较小接种量且因晚期进行性脑膜脑炎而濒死的DBA/2小鼠则无保护作用。尽管在C5充足的小鼠中,针对肺炎的保护作用归因于吞噬细胞在局部的募集,但在用E1保护的C5缺乏小鼠中未观察到这种情况。在这种情况下,IgG抗新型隐球菌抗体似乎是酵母有效调理作用的一种替代方式。总之,这些数据表明,可能有两种主要机制可保护感染小鼠免受早期致命肺炎的侵害:补体对酵母的有效调理作用以及感染组织中吞噬细胞的募集。